Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) (REGISTEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02819882
Recruitment Status : Recruiting
First Posted : June 30, 2016
Last Update Posted : December 3, 2020
Sponsor:
Collaborators:
Hoffmann-La Roche
Novartis
AstraZeneca
Pfizer
Celgene
Information provided by (Responsible Party):
Spanish Breast Cancer Research Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2024
Estimated Study Completion Date : June 2024